openPR Logo
Press release

Neurovascular Stent Retriever Technology Market To Observer Major Growth By 2024

07-17-2017 11:25 PM CET | Health & Medicine

Press release from: Transparency Market Research

Neurovascular Stent Retriever Technology Market To Observer

According to WHO, there are 15 million people across the globe suffering from stroke each year. The incidence of obesity and diabetes has increased over the years and is responsible for the rising prevalence of strokes. Neurovascular stent retriever technology finds application in medical equipment used for the treatment of strokes. The American Heart Association and the American Stroke Association recommend the use of neurovascular stent retrievers for the treatment of strokes. This is driving the global neurovascular stent retriever technology market.

The global neurovascular stent retriever technology market is expected to witness a significant growth in the coming years owing to their use in the treatment of even the most serious cases of stroke with thromboembolic occlusion. The report segments the global neurovascular stent retriever technology market on the basis of technology, geography, and product. The major technologies studied in the report are embolization and coiling, neurothrombectomy, carotid artery angioplasty and stenting, and supporting technologies. The segmentation of the market is done so as to enable a detailed understanding of the performance of each segment of the global neurovascular stent retriever technology market.

The report is compiled through extensive primary research, including surveys, interviews, and observations of expert analysts. Secondary research methods that make use of trade journals, industry databases, and paid sources are also used. The report includes details about the competitive landscape of the global neurovascular stent retriever technology market and profiles key players operating in the market.

View Report :-

http://www.transparencymarketresearch.com/neurovascular-stent-retrievers-market.html 

Overview of the Neurovascular Stent Retriever Technology Market

Technological innovations and advancements in neurovascular stent retriever technology are driving the market. Advancements in neurovascular stent retriever technology are encouraged by various governments, especially in developed countries. This is because there has been a notable improvement in patients owing to the use of neurovascular stent retrievers, thus gaining government support. Moreover, the sedentary lifestyle and unhealthy eating habits of people worldwide are also boosting the global neurovascular stent retriever technology market. However, a dearth of skilled neurosurgeons, coupled with the high level of complexity involved with neurological surgeries, is hampering the growth of the market.

The global neurovascular stent retriever technology market is segmented on the basis of product into snares, suction and aspiration devices, flow diversion devices, embolic coils, clot retrievers, microcatheters, cerebral balloon angioplasty and stenting systems, support devices, embolic protection systems, and carotid artery stents.

By geography, North America leads in the global neurovascular stent retriever technology market owing to the easy accessibility to advanced healthcare options in the region. Favorable reimbursement policies and a strong presence of neurovascular stent retriever device manufacturers in North America are boosting the growth of the market in the region. Significant investments in research and development activities are also helping the market’s growth. Europe and Asia Pacific are the second and the third largest regional segments in the market. The market in Asia Pacific is expected to grow in the coming years due to the dynamic economies of India and China and the rising cases of strokes in the region. The increasing ability of the consumers in the region to afford advanced medical treatment methods is also behind the growth of the region in the neurovascular stent retriever technology market.

Companies Mentioned in the Report

The report profiles the key players operating in the global neurovascular stent retriever technology market. The business and financial overviews of each of the companies are given. The challenges faced by the companies and the strategies adopted by them to stay at the forefront of the market are also given in the report. By offering details such as a company’s recent developments and product history, the report attempts to enlighten readers, helping them gain a competitive edge. The key players in the market are: Stryker, Meril Life Science Pvt .Ltd., Nitinol Devices & Components, Inc., Advent Devices Pvt. Ltd, Medtronic Plc, Norman Noble, INC., Hobbs Medical IN, STI Laser Industries, Ltd., and Akron Inc.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Neurovascular Stent Retriever Technology Market during 2016- 2024

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11195

 

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurovascular Stent Retriever Technology Market To Observer Major Growth By 2024 here

News-ID: 628331 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Neurovascular

Neurovascular Devices Market Size - Forecast to 2026
As per the research conducted by GME, the Neurovascular Devices Market is estimated to be valued at USD 2.87 billion in 2021 and is projected to reach USD 4.37 billion by 2026 at a CAGR of 8.75%. The global neurovascular devices market is being driven by the escalating incidence of neurovascular diseases amongst patients around the world as well as the growing elderly demographic. Browse 151 Market Data Tables and 111
Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market
Neurovascular Devices Market: Opportunities and Challenges
The Neurovascular Devices Market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Increasing research activities in the field of neurovascular therapies Neurovascular devices are witnessing a growing demand among the major stakeholders globally, due to increasing clinical research activities in the field of neurovascular therapies, which offer credible clinical data related to their safety & efficacy
Global Neurovascular Devices Market: Rising Geriatric Population and Neurovascul …
Besides exponential rise in occurrences of critical neurovascular ailments such as ischemic stroke and aneurysm amongst others, burgeoning advances in product enhancements, improved reimbursements, and surged healthcare expenditure are accounted to etch growth in global neurovascular devices market in forthcoming years. These market highlights are in line with Market Research Hub's (MRH) recent research report titled, 'Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 - 2017) and
Future For Neurovascular Devices Market...By 2024
MaketStudyReport.com adds a New Neurovascular Devices Market Research Report for the period of 2018 - 2024 that shows the growth of the market for next few years along with providing a competitive landscape. Neurovascular Devices Market will reach USD 2.0 billion by 2024; as per a new research report. Increasing incidences and financial cost burden associated with neurological disorders such as acute ischemic stroke and brain aneurysm will drive neurovascular devices industry
Neurovascular Devices Market - Regional Outlook 2017 - 2025
Global Neurovascular Devices Market: Snapshot Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes. Endovascular and microsurgical devices are fast gaining traction as minimally invasive techniques for the management of brain aneurysms. In recent years, advances in balloon- and stent- assisted coiling in endovascular therapies have expanded the options for surgeons and patients in the treatment of aneurysms. The rising morbidity and mortality